Viatris Inc.

Viatris Inc. (VTRS)

FDA Applications

Note: This list only includes applications that have been responded to by the FDA.

ApplicationProduct NameActive IngredientFormStrengthStatus
NDA203109 - VIATRIS
REVATIOSILDENAFIL CITRATEFOR SUSPENSION;ORALEQ 10MG BASE/MLPrescription
ANDA084349 - VIATRIS
DILANTINPHENYTOIN SODIUMCAPSULE;ORAL30MG EXTENDEDPrescription
DILANTINPHENYTOIN SODIUMCAPSULE;ORAL100MG EXTENDEDPrescription
NDA022473 - VIATRIS
REVATIOSILDENAFIL CITRATESOLUTION;INTRAVENOUSEQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)Prescription
NDA021845 - VIATRIS
REVATIOSILDENAFIL CITRATETABLET;ORALEQ 20MG BASEPrescription
NDA021269 - VIATRIS
CARDURA XLDOXAZOSIN MESYLATETABLET, EXTENDED RELEASE;ORALEQ 8MG BASEPrescription
CARDURA XLDOXAZOSIN MESYLATETABLET, EXTENDED RELEASE;ORALEQ 4MG BASEPrescription
NDA021134 - VIATRIS
NITROSTATNITROGLYCERINTABLET;SUBLINGUAL0.3MGPrescription
NITROSTATNITROGLYCERINTABLET;SUBLINGUAL0.6MGPrescription
NITROSTATNITROGLYCERINTABLET;SUBLINGUAL0.4MGPrescription
NDA021129 - VIATRIS
NEURONTINGABAPENTINSOLUTION;ORAL250MG/5MLPrescription
NDA020990 - VIATRIS
ZOLOFTSERTRALINE HYDROCHLORIDECONCENTRATE;ORALEQ 20MG BASE/MLPrescription
NDA020919 - VIATRIS
GEODONZIPRASIDONE MESYLATEPOWDER;INTRAMUSCULAREQ 20MG BASE/VIALPrescription
NDA020895 - VIATRIS
VIAGRASILDENAFIL CITRATETABLET;ORALEQ 25MG BASEPrescription
VIAGRASILDENAFIL CITRATETABLET;ORALEQ 50MG BASEPrescription
VIAGRASILDENAFIL CITRATETABLET;ORALEQ 100MG BASEPrescription
NDA020882 - VIATRIS
NEURONTINGABAPENTINTABLET;ORAL800MGPrescription
NEURONTINGABAPENTINTABLET;ORAL600MGPrescription
NDA020825 - VIATRIS
GEODONZIPRASIDONE HYDROCHLORIDECAPSULE;ORALEQ 20MG BASEPrescription
GEODONZIPRASIDONE HYDROCHLORIDECAPSULE;ORALEQ 40MG BASEPrescription
GEODONZIPRASIDONE HYDROCHLORIDECAPSULE;ORALEQ 60MG BASEPrescription
GEODONZIPRASIDONE HYDROCHLORIDECAPSULE;ORALEQ 80MG BASEPrescription
NDA020235 - VIATRIS
NEURONTINGABAPENTINCAPSULE;ORAL400MGPrescription
NEURONTINGABAPENTINCAPSULE;ORAL300MGPrescription
NEURONTINGABAPENTINCAPSULE;ORAL100MGPrescription
NDA019839 - VIATRIS
ZOLOFTSERTRALINE HYDROCHLORIDETABLET;ORALEQ 50MG BASEPrescription
ZOLOFTSERTRALINE HYDROCHLORIDETABLET;ORALEQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**Discontinued
ZOLOFTSERTRALINE HYDROCHLORIDETABLET;ORALEQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**Discontinued
ZOLOFTSERTRALINE HYDROCHLORIDETABLET;ORALEQ 100MG BASEPrescription
ZOLOFTSERTRALINE HYDROCHLORIDETABLET;ORALEQ 25MG BASEPrescription
NDA019787 - VIATRIS
NORVASCAMLODIPINE BESYLATETABLET;ORALEQ 2.5MG BASEPrescription
NORVASCAMLODIPINE BESYLATETABLET;ORALEQ 5MG BASEPrescription
NORVASCAMLODIPINE BESYLATETABLET;ORALEQ 10MG BASEPrescription
NDA019668 - VIATRIS
CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 1MG BASEPrescription
CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 2MG BASEPrescription
CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 8MG BASEPrescription
CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 4MG BASEPrescription
NDA008762 - VIATRIS
DILANTIN-125PHENYTOINSUSPENSION;ORAL125MG/5MLPrescription
DILANTIN-30PHENYTOINSUSPENSION;ORAL30MG/5MLDiscontinued